The US Chamber and Pugatch Consilium launch the third edition of the GIPC IP Index

Posted by:

The US Chamber and Pugatch Consilium launch the third edition of the GIPC IP Index

This week Pugatch Consilium, in partnership with the US Chamber’s Global Intellectual Property Center, released the third edition of the annual GIPC International IP Index. The 2015 edition of the Index, entitled UP: Unlimited Potential, maps the intellectual property environment in 30 economies. Overall, although challenges remain across the board, positive steps are being taken in many of the economies included in the Index. In fact, 20 of the economies mapped in 2014 improved their scores in the 2015 edition. The ...

Continue Reading →
0

Innovation, Intellectual Property, Market Analysis, Pharmaceuticals & Healthcare

New article in IP Today – Staying Ahead: How Can Robust IP Protection Help Countries Prepare for the Next Ebola?

Posted by:

New article in IP Today – Staying Ahead: How Can Robust IP Protection Help Countries Prepare for the Next Ebola?

This week IP Today published an article by Pugatch Consilium Partner, Rachel Chu.

Looking at the race to develop the Ebola vaccine as well as other new medicines, the article draws a connection between investment in R&D, clinical trials and the protection of IPRs – all aimed at developing next generation healthcare technologies and medicines.

“Although increasing resources directed towards the health system is among the most obvious steps policymakers can take, one element often overlooked is the level of support toward ...

Continue Reading →
0

Intellectual Property, Pharmaceuticals & Healthcare

Developing a Culture of Pharmacovigilance

Posted by:

Developing a Culture of Pharmacovigilance

Today Pugatch Consilium launches Developing a Culture of Pharmacovigilance. Authored by Professor Meir Pugatch, Dr David Torstensson and Ma’ayan Laufer this report examines one of the most important facets of a high quality drug regulatory structure, namely that of pharmacovigilance.

Pharmacovigilance is the name given to the mechanisms and tests that together map and ensure the safety of a medicine throughout its life span – from test tube to patient. As patients and healthcare professionals around the world access and ...

Continue Reading →
0

Intellectual Property, Market Analysis, Pharmaceuticals & Healthcare

Understanding the drivers of biopharmaceutical clinical research: Why do some countries get all the investment?

Posted by:

Understanding the drivers of biopharmaceutical clinical research: Why do some countries get all the investment?

Today Pugatch Consilium releases Scaling Up Global Clinical Trial Activity: Key Trends and Policy Lessons. This study uses regression analysis of data on 50 countries to provide a roadmap for creating a policy environment that is conducive to clinical trials. The study also benchmarks performance in the level of scope of clinical trial activity.
The main messages of the report are:

  • The creation of a pro-innovation culture is just as, if not more, important as improvements to health system capacity for ...
Continue Reading →
0

Market Analysis, Pharmaceuticals & Healthcare

The Creative Industries and the BRICS – full report is now available on our site!

Posted by:

The Creative Industries and the BRICS – full report is now available on our site!

A review of the state of the creative economy in Brazil, Russia, India, China and South Africa

This review examines the state of the creative economy in the biggest emerging economies in the world namely Brazil, Russia, India, China and South Africa – the BRICS. Although at different levels of development, these economies are in many ways undergoing similar transitions from economies based on manufacturing, industrial output and natural resources to economies in which economic activity is ...

Continue Reading →
0

Intellectual Property, Market Analysis

Dr David Torstensson speaks on clinical trials transparency at American Chamber of Commerce to the EU in Brussels

Posted by:

Dr David Torstensson speaks on clinical trials transparency at American Chamber of Commerce to the EU in Brussels

Pugatch Consilium Partner, Dr Torstensson presented the main findings of the Pugatch Consilium report Heading in a Different Direction? The European Medicines Agency’s Policy on the Public Release of Clinical Trials Data at the report’s EU launch. The launch took place at the AmCham EU offices in Brussels, Belgium.

The report was commissioned by the US Chamber of Commerce’s GIPC. It examines the debate and policies in place on public disclosure of clinical trials data and information in Europe, the US, ...

Continue Reading →
0

Intellectual Property, Pharmaceuticals & Healthcare

Page 5 of 14 «...34567...»